Dentsply Sirona’s PrimeTaper EV Implant Earns 99% Survival Rate in Real-World Study

Dentsply Sirona and the McGuire Institute (iMc), a nonprofit practice-based research network of periodontists and oral surgeons across the United States, have launched the PrimeTaper EV Implant Registry to evaluate its performance in diverse, real-world clinical settings. With over 300 clinicians from across the U.S. contributing data on nearly 2,000 implants, the registry has revealed an impressive 99% survival rate for the PrimeTaper EV Implant to date.

The EV connection from PrimeTaper is the first implant-abutment connection designed for digital workflows. with its one-position-only placement option.

PrimeTaper EV Implant Demonstrates High Clinical Reliability

The registry has become an invaluable resource, offering critical insights into the implant’s performance across a range of practice environments. Study participants include a broad spectrum of clinicians, from general practitioners to specialists, encompassing both recent graduates and seasoned professionals. The patient demographics are equally varied, including individuals with unremarkable medical histories as well as those with significant comorbidities. Despite this diversity, participants in the study report outstanding results, with 96% of clinicians rating their experience with the PrimeTaper EV during surgical placement as either “good” or “very good,” according to the top two categories of a Handling Survey questionnaire. This feedback reflects the implant’s high reliability, ease of use, and versatility in handling various bone densities, contributing to efficient procedures and optimal patient outcomes.

“Research is critical to the development of our next-generation solutions,” said Tony Susino, GVP Implant & Prosthetic Solutions at Dentsply Sirona. “The real-world evidence obtained through this clinical registry provides valuable insights into the day-to-day experiences of clinicians, helping us better understand how we can continue to meet their needs and ultimately advance dentistry—for the benefit of clinicians and patients alike.”

PrimeTaper EV Implant Continues to Transform Digital Implant Dentistry

PrimeTaper EV Implant is a modern, fully tapered, self-tapping implant inspired by the proven Astra Tech Implant EV. It is designed for efficient placement, predictable implant installation, and secure placement across varying bone densities. Implant clinicians benefit from its efficient handling, lasting bone care, enviable esthetics, and seamless integration into digital workflows.

“PrimeTaper EV Implant has great handling with its consistent torque build,” said Todd Scheyer, DDS, from Houston, Texas. “The taper and unique thread design make immediate installation easy, and it fits well with our digital workflow, making it more efficient. With the key features of Astra Tech Implant EV included in this modern implant, such as the OsseoSpeed surface and EV connection, it is a joy to have the PrimeTaper Implant System as part of our practice and a benefit to our patients.”

The real-world evidence gathered in this study is another example of Dentsply Sirona’s commitment to its mission of transforming dentistry to improve oral health globally.

For more information about PrimeTaper EV Implant, please visit https://www.dentsplysirona.com/en-us/discover/discover-by-brand/ds-primetaper.html.

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.

Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care.

Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.